Biodesix Inc
NASDAQ:BDSX
Biodesix Inc
NASDAQ:BDSX
Price:
11.45
USD
5.68%
Market Closed
Market Cap:
$91.1m
Balance Sheet
Balance Sheet Decomposition
Biodesix Inc
Biodesix Inc
Balance Sheet Decomposition is not available for
Biodesix Inc
Biodesix Inc
Balance Sheet
Biodesix Inc
Biodesix Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
6
|
5
|
62
|
33
|
43
|
26
|
26
|
|
| Cash Equivalents |
6
|
5
|
62
|
33
|
43
|
26
|
26
|
|
| Total Receivables |
2
|
5
|
15
|
4
|
5
|
8
|
9
|
|
| Accounts Receivables |
2
|
5
|
15
|
4
|
5
|
8
|
9
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
2
|
2
|
9
|
7
|
5
|
6
|
5
|
|
| Total Current Assets |
10
|
13
|
86
|
44
|
53
|
40
|
39
|
|
| PP&E Net |
1
|
2
|
3
|
4
|
9
|
30
|
30
|
|
| PP&E Gross |
1
|
2
|
3
|
4
|
9
|
30
|
30
|
|
| Accumulated Depreciation |
6
|
6
|
7
|
7
|
7
|
6
|
9
|
|
| Intangible Assets |
17
|
15
|
13
|
12
|
10
|
8
|
6
|
|
| Goodwill |
11
|
12
|
15
|
15
|
15
|
15
|
15
|
|
| Other Long-Term Assets |
0
|
0
|
4
|
2
|
6
|
7
|
7
|
|
| Other Assets |
11
|
12
|
15
|
15
|
15
|
15
|
15
|
|
| Total Assets |
39
N/A
|
42
+6%
|
121
+191%
|
76
-37%
|
93
+22%
|
99
+7%
|
97
-2%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
2
|
9
|
2
|
2
|
3
|
2
|
|
| Accrued Liabilities |
2
|
2
|
5
|
5
|
7
|
5
|
8
|
|
| Short-Term Debt |
0
|
12
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
12
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
7
|
7
|
22
|
14
|
25
|
4
|
|
| Total Current Liabilities |
5
|
23
|
32
|
29
|
23
|
33
|
14
|
|
| Long-Term Debt |
23
|
24
|
16
|
10
|
25
|
35
|
36
|
|
| Other Liabilities |
26
|
30
|
32
|
17
|
25
|
26
|
26
|
|
| Total Liabilities |
53
N/A
|
76
+44%
|
80
+5%
|
56
-29%
|
72
+28%
|
95
+31%
|
76
-19%
|
|
| Equity | ||||||||
| Common Stock |
184
|
194
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
200
|
231
|
259
|
302
|
367
|
420
|
462
|
|
| Additional Paid In Capital |
2
|
2
|
300
|
322
|
388
|
424
|
483
|
|
| Total Equity |
14
N/A
|
35
-145%
|
41
N/A
|
20
-52%
|
21
+5%
|
5
-78%
|
21
+356%
|
|
| Total Liabilities & Equity |
39
N/A
|
42
+6%
|
121
+191%
|
76
-37%
|
93
+22%
|
99
+7%
|
97
-2%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
2
|
4
|
5
|
7
|
|
Switch to:
Switch to:
See Also
Discover More
